Evidence map›Paper›PMID 34733998›Full record

ArticleAnnals of translational medicine2021

Comparison of severe and critical COVID-19 patients imported from Russia with and without influenza A infection in Heilongjiang Province: a retrospective study.

Qingqing Dai, Ming Ye, Zhiqiang Tang, Kaijiang Yu, Yang Gao, Zhenyu Yang, Junbo Zheng, Shu Zuo, Yan Liu, Fengjie Xie and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Qingqing DaiDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ming YeDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhiqiang TangDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Kaijiang YuDepartment of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yang GaoDepartment of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhenyu YangDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Junbo ZhengDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Shu ZuoDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan LiuDepartment of Medical Statistics, Harbin Medical University, Harbin, China.
Fengjie XieDepartment of Critical Care Medicine, Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, China.
Qiuyuan HanDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Hua HeDepartment of Infectious Disease, Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, China.
Hongliang WangDepartment of Critical Care Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Second Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNMudanjiang Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rapid spread of coronavirus disease-19 (COVID-19) poses a global health emergency, and cases entering China from Russia are quite diverse. This study explored and compared the clinical characteristics and outcomes of severe and critically ill COVID-19 patients from Russia with and without influenza A infection, treated in a northern Chinese hospital (Russia imported patients).

methodsA total of 32 severe and critically ill Russia-imported COVID-19 patients treated in the Heilongjiang Imported Severe and Critical COVID-19 Treatment Center from April 6 to May 11, 2020 were included, including 8 cases (group A) with and 24 cases (group B) without influenza A infection. The clinical characteristics of each group were compared, including prolonged hospital stay, duration of oxygen therapy, time from onset to a negative SARS-CoV-2 qRT-PCR RNA (T

resultsThe results showed that blood group, PaO

conclusionsInfluenza A infection is common in Russia-imported COVID-19 patients, which can prolong the hospital stay and duration of bacterial infection. Routinely screening and treating influenza A should be conducted early in such patients.

Indexed as

clinical characteristicsclinical outcomeCoronavirus disease-19 influenza A (COVID-19 influenza A)imported patients

Identifiers

PMID34733998
PMCPMC8506785
OpenAlexW3196690564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.